Telo Genomics Income Statement

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Selling, General & Admin	1.35	1.31	1.36	1.46	0.99	0.65
Research & Development	1.34	1.39	1.36	1.36	1.12	0.6
Total Operating Expenses	2.69	2.7	2.72	2.82	2.11	1.26
Operating Income	-2.69	-2.7	-2.72	-2.82	-2.11	-1.26
Total Non-Operating Income (Expense)	0.02	0.02	0.01	-	-	0.19
Pretax Income	-2.67	-2.69	-2.71	-2.82	-2.11	-1.07
Net Income	-2.71	-2.72	-2.71	-2.82	-2.11	-1.07
Net Income to Common	-2.71	-2.72	-2.71	-2.82	-2.11	-1.07
Shares Outstanding (Basic)	94	88	71	60	59	47
Shares Outstanding (Diluted)	94	88	71	60	59	47
Shares Change (YoY)	30.60%	22.92%	18.67%	2.54%	25.11%	56.67%
EPS (Basic)	-0.04	-0.03	-0.04	-0.05	-0.04	-0.02
EPS (Diluted)	-0.04	-0.03	-0.04	-0.05	-0.04	-0.02
Free Cash Flow	-2.17	-2.33	-2.46	-2.7	-1.82	-1.11
Free Cash Flow Per Share	-0.02	-0.03	-0.03	-0.04	-0.03	-0.02
EBITDA	-2.68	-2.69	-2.68	-2.79	-2.05	-1.19
EBIT	-2.69	-2.7	-2.72	-2.82	-2.11	-1.26

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.